Showing results (171-180 of 408) with videos related to

Sort By:
Pageof 41
PLOS Digital Health|February 24, 2026
Taking a closer look: Can an app improve diagnostic accuracy in urgent care? Cluster-randomized interventional trial DASIEva Maria Noack, Kai Antweiler, Tim Friede, et al.
Research Synthesis Methods|January 24, 2021
On weakly informative prior distributions for the heterogeneity parameter in Bayesian random-effects meta-analysisChristian Röver, Ralf Bender, Sofia Dias, et al.
Statistics in Medicine|September 28, 2011
Considerations on what constitutes a 'qualified statistician' in regulatory guidelinesChristoph Gerlinger, Lutz Edler, Tim Friede, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 20, 2021
Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical careKris Oliver Jalusic, David Ellenberger, Paulus Rommer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 28, 2010
A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosisJeremy Chataway, Richard Nicholas, Susan Todd, et al.
Plos One|September 13, 2016
Gender Differences in Appropriate Shocks and Mortality among Patients with Primary Prophylactic Implantable Cardioverter-Defibrillators: Systematic Review and Meta-AnalysisDavid Conen, Barbora Arendacká, Christian Röver, et al.
European Journal of Heart Failure|April 17, 2023
Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: A Bayesian meta-analysisStefan D Anker, Muhammad Shahzeb Khan, Javed Butler, et al.
Neurology|October 23, 2016
Evaluation of dysphagia by novel real-time MRIArno Olthoff, Per-Ole Carstens, Shuo Zhang, et al.
JAMA Neurology|July 16, 2019
Association of Obesity With Multiple Sclerosis Risk and Response to First-line Disease Modifying Drugs in ChildrenBrenda Huppke, David Ellenberger, Hannah Hummel, et al.
Therapeutic Advances in Neurological Disorders|September 29, 2023
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across EuropeRichard Nicholas, Jeff Rodgers, James Witts, et al.
Pageof 41